Baker McKenzie advised the underwriters on the deal. OrbusNeich Medical Group executed an initial public offering. OrbusNeich Medical is a major global medical device manufacturer specializing...
OrbusNeich Medical Group’s Initial Public Offering
OrbusNeich Medical Group’s US$61.6 Million Initial Public Offering
Baker McKenzie advised the underwriters on the deal while O’Melveny represented OrbusNeich Medical Group. OrbusNeich Medical Group Holdings Limited (6929.HK) announced its approximate US$61.6 million (approximately HK$481...
Joincare Pharmaceutical’s GDR Listing on SIX Swiss Exchange
Baker McKenzie advised CLSA Limited and other underwriters in the deal. Advestra and JunHe advised Joincare Pharmaceutical Group Industry Co., Ltd. Joincare Pharmaceutical executed a GDR listing...
Joincare Pharmaceutical’s GDR listing on SIX Swiss Exchange
Baker McKenzie advised CLSA Limited and other underwriters in the deal. Joincare Pharmaceutical executed a GDR listing on SIX Swiss Exchange Joincare Pharmaceutical is an innovation-driven integrated...